NCT05843409

Brief Summary

Mindfulness-Based Cognitive Therapy (MBCT) combines ideas of traditional cognitive therapies with meditative practices aimed at cultivating mindfulness. Mindfulness-based stress reduction (MBSR) is considered one of the original mindfulness-based interventions. It has been modified to be offered virtually,which has been useful throughout the COVID pandemic, and more importantly, has served to inform other mindfulness approaches, such as trauma-focused therapy. The investigators want to assess the efficacy of MBSR in patients with Chronic Pain undergoing drug treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable chronic-pain

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

May 10, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
Last Updated

January 30, 2024

Status Verified

January 1, 2024

Enrollment Period

12 months

First QC Date

April 12, 2023

Last Update Submit

January 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Chronic pain assessed with the Brief Pain Inventory (BPI)

    Chronic or persistent pain is pain that carries on for longer than 12 weeks despite medication or treatment.

    1 year

Secondary Outcomes (2)

  • Quality of life assessore with EQ5D

    1 year

  • Drug assumption

    1 year

Study Arms (2)

Control

NO INTERVENTION

Normal drug therapie or usual treatment

Intervention

EXPERIMENTAL

Normal drug therapie or usual treatment with add Mindfulness-based stress reduction (MBSR)

Behavioral: Mindfulness-based stress reduction (MBSR)

Interventions

Mindfulness-based stress reduction may be associated with short-term effects on pain intensity and physical functioning. Patients will be randomized into 2 groups. The experimental group will receive MBSR sessions, with the frequency and duration specified in the study protocol. The sessions will be free and carried out by expert staff

Intervention

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients being treated for Chronic Pain
  • Patients with Chronic Pain in Pharmacological Therapy

You may not qualify if:

  • Patients with Chronic Pain not in Pharmacological Therapy
  • Patients without Chronic Pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ASST Lecco

Lecco, 23814, Italy

RECRUITING

Related Publications (1)

  • Damico V, Milani M, Murano L. Effect of Mindfulness-Based Stress Reduction on Patients With Chronic Pain: A Randomized Controlled Trial. Pain Manag Nurs. 2025 Oct;26(5):510-522. doi: 10.1016/j.pmn.2025.02.010. Epub 2025 Mar 13.

MeSH Terms

Conditions

Chronic Pain

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Vincenzo Damico

    Rn PhD, Department of Anesthesia and Critical Care, Asst Lecco

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized Controlled Trial (RCT)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator: Vincenzo Damico, Registered Nurse, Doctor of Philosophy, Department of Anesthesia and Critical Care, Azienda Socio Sanitaria Territoriale of Lecco

Study Record Dates

First Submitted

April 12, 2023

First Posted

May 6, 2023

Study Start

May 10, 2023

Primary Completion

April 30, 2024

Study Completion

May 30, 2024

Last Updated

January 30, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations